Molecular Tumor Board: 87-year-old male with HER2 overexpressed muscle invasive high-grade urothelial carcinoma

In our latest Molecular Tumor Board, our Medical Affairs team reviews a case of muscle-invasive bladder cancer with HER2 overexpression. They highlight the recent approval of tumor-agnostic HER2 biomarker in solid tumors and explore key differences between the available testing modalities for HER2 overexpression across various tumor types.